Tender Results of Aok Rheinland Hamburg Die Gesundheitskasse

Completion of non-exclusive discounts pursuant to § 130a para. 8 SGB W at any time with a so-called closing option ‘open-house contracts’ for aripiprazole (excluding dosage form tablets,) eprosartan, eprosartan/HCT, hydromorphone (excluding retarded dosage forms), pankreatin (ATC code according to WHO: A09AA02,) biperids and fusidic acid.

Completion of non-exclusive discounts according to § 130a para. 8 SGB V with any possibility to conclude at so-called ‘Open-House contracts’ for medicinal active substances Teriparatid and Palonosetron.

Papier

Power supply.

Completion of non-exclusive discounts according to § 130a para. 8 SGB V with any possibility to conclude at so-called ‘open-house contracts’ for linezolide and fentanyl (except dosage form matrix plaster (plant transdermal).

Data protection law.

Completion of non-exclusive discounts according to § 130a para. 8 SGB V with any possibility to conclude at so-called ‘Open-House contracts’ for the active substance Peginterferon alpha-2a.

Completion of non-exclusive discounts according to § 130a para. 8 SGB V with any possibility to conclude at so-called ‘Open-House contracts’ for medicinal active substances Valganciclovir (Darreichungsform Filmtablette), Macrogol and Paricalcitol.

Completion of non-exclusive discounts according to § 130a para. 8 SGB W at any time with a so-called closing option ‘open-house contracts’ for the active substance of the medicinal product Entacapon.

Medicinal active ingredient combination: Ivabradin/Metoprolol.